74760 US KLM Department of Medical Biochemistry, two (2) Coagulation Instruments

Oslo Universitetssykehus HF

Oslo University Hospital invites tenderers to a competition for the procurement of 2 coagulation instruments for the Department of Medical Biochemistry, Ullevål.
The Department of Medical Biochemistry at Oslo University Hospital is organised in 4 different operational divisions that all use coagulation analyses. At Ullevål Hospital, two STA-R Evolution devices shall be replaced with 2 new coagulation instruments. The new instruments shall not be connected to the band. The instruments will be operated throughout the entire day and handle approximately 60 000 citrate tubes for coagulation per year. Approximately 53 000 PT-INR, 18 000 APTT, 15000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.

Frist

Fristen for mottak av tilbud var 2017-06-07. Anskaffelsen ble publisert 2017-04-19.

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2017-04-19 Kunngjøring av konkurranse
2018-01-19 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2017-04-19)
Gjenstand
Anskaffelsens omfang
Tittel: Laboratory, optical and precision equipments (excl. glasses)
Referansenummer: 74760
Kort beskrivelse:
Oslo University Hospital invites tenderers to a competition for the procurement of 2 coagulation instruments for the Department of Medical Biochemistry, Ullevål. The Department of Medical Biochemistry at Oslo University Hospital is organised in 4 different operational divisions that all use coagulation analyses. At Ullevål Hospital, two STA-R Evolution devices shall be replaced with 2 new coagulation instruments. The new instruments shall not be connected to the band. The instruments will be operated throughout the entire day and handle approximately 60 000 citrate tubes for coagulation per year. Approximately 53 000 PT-INR, 18 000 APTT, 15000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Laboratorie-, optisk- og presisjonsutstyr (bortsett fra briller) 📦
Tilleggs-CPV: Blodanalyseapparater 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Offentligrettslig organ
Navn på tildelende myndighet: Oslo universitetssykehus HF
Postadresse: Postboks 4950 Nydalen
Postnummer: 0424
Poststed: Oslo
Kontakt
Internettadresse: https://oslo-universitetssykehus.no/ 🌏
E-post: lanarv@ous-hf.no 📧
Telefon: +47 92081843 📞
URL for dokumenter: https://kgv.doffin.no/ctm/Supplier/Documents/Folder/153744 🌏

Referanse
Datoer
Sendt dato: 2017-04-19 📅
Innleveringsfrist: 2017-06-07 📅
Publiseringsdato: 2017-04-21 📅
Identifikatorer
Kunngjøringsnummer: 2017/S 078-151680
OJ-S-utgave: 78

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
Oslo University Hospital invites tenderers to a competition for the procurement of 2 coagulation instruments for the Department of Medical Biochemistry, Ullevål.
The Department of Medical Biochemistry at Oslo University Hospital is organised in 4 different operational divisions that all use coagulation analyses. At Ullevål Hospital, two STA-R Evolution devices shall be replaced with 2 new coagulation instruments. The new instruments shall not be connected to the band. The instruments will be operated throughout the entire day and handle approximately 60 000 citrate tubes for coagulation per year. Approximately 53 000 PT-INR, 18 000 APTT, 15000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.
Vis mer
Estimert totalverdi: 5 000 000 NOK 💰
Kort beskrivelse:
The Department of Medical Biochemistry at Oslo University Hospital is organised in 4 different operational divisions that all use coagulation analyses. At Ullevål Hospital, two STA-R Evolution devices shall be replaced with 2 new coagulation instruments. The new instruments shall not be connected to the band. The instruments will be operated throughout the entire day and handle approximately 60 000 citrate tubes for coagulation per year. Approximately 53 000 PT-INR, 18 000 APTT, 15 000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.
Vis mer
In addition the contracting authority would like option(s) for the following:
6 coagulation instruments;
Service agreements;
Consumables (equipment specific).
Estimert verdi eksklusive mva: 5 000 000 NOK 💰
Varighet: 120 måneder
Beskrivelse av opsjoner:
In addition the contracting authority would like option(s) for the following:
6 coagulation instruments;
Service agreements;
Consumables (equipment specific).
Utførelsessted
Hovedsted eller utførelsessted: Oslo University HF [Oslo University Hospital].

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten: See the tender documentation.
Kontraktutførelse
Vilkår for kontraktoppfyllelse: See the tender documentation.

Prosedyre
Begrunnelse for rammeavtalen: Equipment specific consumables.
Tidspunkt for mottak av tilbud: 12:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: dansk 🗣️
norsk 🗣️
+ 1 til svensk 🗣️
Tilbudets gyldighetsperiode: 2017-10-31 📅
Dato for åpning av tilbud: 2017-06-07 📅
Tidspunkt for åpning av tilbud: 12:00

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 993 467 049
Kontakt
Kontaktpunkt: Lars Narvhus
Adresse til kjøperprofilen: https://kgv.doffin.no/ctm/Company/CompanyInformation/Index/2903 🌏
URL for dokumenter: https://kgv.doffin.no/ctm/Supplier/Documents/Folder/153744 🌏

Utfyllende informasjon
Klageinstans
Navn: Oslo Universitetssykehus HF
Postadresse: Postboks 4950 Nydalen
Poststed: Oslo
Postnummer: 0424
Land: Norge 🇳🇴
E-post: mtu-anbud@ous-hf.no 📧
Informasjon om frister for klage: See the tender documentation.
Tjeneste hvor informasjon om klageprosedyren kan innhentes
Samme som: Klageinstans
Kilde: OJS 2017/S 078-151680 (2017-04-19)
Kunngjøring om tildeling av kontrakt (2018-01-19)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
Oslo University Hospital invites tenderers to a competition for the procurement of 2 coagulation instruments for the Department of Medical Biochemistry, Ullevål. The Department of Medical Biochemistry at Oslo University Hospital is organised in 4 different operational divisions that all use coagulation analyses. At Ullevål Hospital, 2 STA-R Evolution devices shall be replaced with 2 new coagulation instruments. The new instruments shall not be connected to the band. The instruments will be operated throughout the entire day and handle approximately 60 000 citrate tubes for coagulation per year. Approximately 53 000 PT-INR, 18 000 APTT, 15 000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.
Vis mer
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Oppdragsgiver
Identitet
Postadresse: Postboks 4950, Nydalen

Referanse
Datoer
Sendt dato: 2018-01-19 📅
Publiseringsdato: 2018-01-20 📅
Identifikatorer
Kunngjøringsnummer: 2018/S 014-029959
Refererer til kunngjøring: 2017/S 078-151680
OJ-S-utgave: 14
Tilleggsinformasjon
Oslo University Hospital is of the opinion that the requirement specifications for coagulation instruments, subpoint II.8 “level difference with reference to existing equipment at OUS” favours one tenderer and is an illegal award criterium. Cf. Public Procurements Act § 15.1 (4), Oslo University Hospital is of the opinion that this is an error that, at this stage, cannot be fixed by any other means than cancelling the competition. Cf. Public Procurements Act § 25.4.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Department of Medical Biochemistry at Oslo University Hospital is organised in 4 different operational divisions that all use coagulation analyses. At Ullevål Hospital, 2 STA-R Evolution devices shall be replaced with 2 new coagulation instruments. The new instruments shall not be connected to the band. The instruments will be operated throughout the entire day and handle approximately 60 000 citrate tubes for coagulation per year. Approximately 53 000 PT-INR, 18 000 APTT,
15 000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.
15000 D-dimer, 11 000 Fibrinogen, 3 750 Antitrombin and 750 Anti factor Xa (LMWH/heparin), will be performed including control analyses. The department offers immediate help services and must have an instrument available at all times. The two offered instruments should be of the same model.
In addition the Contracting Authority would like option(s) for the following:
— 6 coagulation instruments,
— Service agreements,
— Consumables (equipment specific).
Beskrivelse av opsjoner:
In addition the Contracting Authority would like option(s) for the following:
— 6 coagulation instruments,
— Service agreements,
— Consumables (equipment specific).

Prosedyre
Tildelingskriterier
Kvalitetskriterium (navn): Functional requirements
Kvalitetskriterium (vekting): 70 %
Vekting av pris: 30 %

Referanse
Tilleggsinformasjon
Oslo University Hospital is of the opinion that
the requirement specifications for coagulation instruments, subpoint II.8 “level difference with reference to existing equipment at OUS” favours one tenderer and is an illegal award criterium. Cf. Public Procurements Act § 15.1 (4),
this is an error that, at this stage, cannot be fixed by any other means than cancelling the competition. Cf. Public Procurements Act § 25.4.
Kilde: OJS 2018/S 014-029959 (2018-01-19)